Global Bioprocess Analyzers Market Drivers
The global bioprocess analyzer market is expected to witness significant growth over the forecast period due to increasing launches of new technology by the key players. For instance, in August 2019, Rebel was launched by 908 Devices, a manufacturer of analytical devices for chemical and bimolecular analysis. Rebel is a cell media analyzer for bioprocess labs, which helps the biopharma researchers to accelerate the process development cycle as well maximize bioreactor utilization by running media analysis at line (production). Furthermore, Rebel helps in analysis as well identification of amino acids, biogenic amines, amino acids, and water soluble vitamins.
Moreover, in June 2019, Cypher One, which is an automated hem agglutination analyzer, single step high throughput solution for rapid and automated analysis of hem agglutination (HA) and hem agglutination inhibition (HAI) assays was launched by Biogenuix Medsystems Private Limited.
Global Bioprocess Analyzers Market Restraints
However, bioprocess is time consuming as compared to the chemical process method, which is one of the major restraints that is expected to hamper growth of the global bioprocess analyzer market. Moreover, difficulties associated with downstream bioprocess is another factor that is expected to hamper the growth of global bioprocess analyzers. For instance, increasing volume, cell densities, and protein masses are some major difficulties of downstream bioprocess that biopharma researcher generally face. In addition, small-sized bioprocessing equipment also creates problem for purifying the material or substance.
Bioprocess Analyzer Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients